Trimethylaminuria

Last updated
Trimethylaminuria
Other namesPrimary trimethylaminuria
Trimethylamine chemical structure.png
Trimethylamine
Specialty Endocrinology   OOjs UI icon edit-ltr-progressive.svg

Trimethylaminuria (TMAU), also known as fish odor syndrome or fish malodor syndrome, [1] is a rare metabolic disorder that causes a defect in the normal production of an enzyme named flavin-containing monooxygenase 3 (FMO3). [2] [3] When FMO3 is not working correctly or if not enough enzyme is produced, the body loses the ability to properly convert the fishy-smelling chemical trimethylamine (TMA) from precursor compounds in food digestion into trimethylamine oxide (TMAO), through a process called N-oxidation.

Contents

Trimethylamine then builds up and is released in the person's sweat, urine, and breath, giving off a fishy odor. Primary trimethylaminuria is caused by genetic mutations that affect the FMO3 function of the liver. Symptoms matching TMAU can also occur when there is no genetic cause, yet excessive TMA is excreted - this has been described as secondary trimethylaminuria (TMAU2).

Metabolic pathway

Trimethylamine enters the body via the consumption of certain foods and supplements:

TMA in the gut is absorbed through the intestinal lining and enters the bloodstream, where it is processed by the liver. A healthy liver produces an abundance of the enzyme FMO3, which neutralises the TMA by oxidising it to an odourless TMAO. If FMO3 enzyme production is compromised, or there is too much TMA for the amount of enzyme, then TMA will continue to circulate in the bloodstream until enough enzyme is produced. While TMA is in the bloodstream, it is filtered out via the kidneys (95% over 24 hours [9] ) to the bladder, and slowly exits the body in bodily fluids; urine, sweat, saliva, reproductive fluids and breath. TMA has no known interactions with any known internal or organ function.

Although lecithin, creatinine and betaine are technically precursors to TMA, pilot studies have shown no significant effect on the production of excess TMA/TMAO in urinary analysis at normal dietary levels of consumption. [5] When taken in large quantities (12g/day) betaine has been known to cause fish odor symptoms, [10] meaning that there is some conversion of betaine to TMA if supplements are taken regularly.

Symptoms and signs

Trimethylamine is most noticeable in urine, as it is captured, concentrated and released in intervals. Fishy smelling urine is a primary identifying symptom in infant children (Trimethylaminuria literally meaning "trimethylamine in urine").

Trimethylamine is also released in the person's sweat, reproductive fluids, and breath, and can give off a fishy odor when the concentration of trimethylamine is high enough to be detected. The intensity of the smell is directly correlated with the concentration of trimethylamine in the bloodstream.

People with TMAU may have an intermittent fish-like body odor, depending on diet and the severity of their FM03 mutation. In a study by Wise PM, [11] of 115 positively identified TMAU subjects, after a choline challenge load test (intentionally ingesting a TMA precursor) only 10% expressed a smell at a social distance. When in a fasted state (12 hours) 0% had a smell detectable at a social distance and only 5% had some minor malodour at an intimate distance. These findings suggested that those that produced an odour had a more severe form of FMO3 impairment.

Smell events are often sporadic and episodic in nature (based on diet over the previous 24 hours), making it often difficult to diagnose by smell alone. Some people with trimethylaminuria report having a strong odor all the time, but there has not been any evidence apart from self reported symptoms that this is the case.

Individuals with this condition do not have any physical symptoms, and they typically appear healthy. [12]

The condition seems to be more common in women than men, for unknown reasons. Scientists suspect that such female sex hormones as progesterone and estrogen aggravate the condition. According to several reports, the condition worsens around puberty. In women, symptoms may worsen just before and during menstrual periods, after taking oral contraceptives, and around menopause. [12]

Genetics

Trimethylaminuria has an autosomal recessive pattern of inheritance. Autorecessive.svg
Trimethylaminuria has an autosomal recessive pattern of inheritance.

Most cases of trimethylaminuria appear to be inherited in an autosomal recessive pattern, which means two copies of the gene in each cell are altered. The parents of an individual with an autosomal recessive disorder are both carriers of one copy of the altered gene. Carriers may have mild symptoms of trimethylaminuria or experience temporary episodes of fish-like body odor.[ citation needed ]

Mutations in the FMO3 gene, which is found on the long arm of chromosome 1, cause trimethylaminuria. The FMO3 gene makes an enzyme that breaks down nitrogen-containing compounds from the diet, including trimethylamine. These compounds are produced by bacteria in the intestine as they digest proteins from eggs, meat, soy, and other foods. Normally, the FMO3 enzyme converts fishy-smelling trimethylamine into trimethylamine N-oxide which has no odor. If the enzyme is missing or its activity is reduced because of a mutation in the FMO3 gene, trimethylamine is not broken down and instead builds up in the body. As the compound is released in a person's sweat, urine, and breath, it causes the strong odor characteristic of trimethylaminuria. Researchers believe that stress and diet also play a role in triggering symptoms.[ citation needed ]

There are more than 40 known mutations associated with TMAU. [13] [14] [15] Loss-of-function mutations, nonsense mutations, and missense mutations are three of the most common. Nonsense and missense mutations cause the most severe phenotypes.

In 2007 the evolution of the FMO3 gene was studied, including the evolution of some mutations associated with TMAU. [16]

Diagnosis

Measurement of urine for the ratio of trimethylamine to trimethylamine N-oxide is the standard screening test. A blood test is available to provide genetic analysis. The prominent enzyme responsible for TMA N-oxygenation is coded by the FMO3 gene.

False positives can occur in the following conditions, where elevated TMA can be present in the urine without any underlying TMAU:

A similar foul-smelling odor of the urine has also been associated with colonization of the urinary tract with a bacterium called Aerococcus urinae , especially in children. [18]

Olfactory reference syndrome is a condition where there is a persistent false belief and preoccupation with the idea of emitting an abnormal body odor. According to McNiven [19] at a Canadian genetics clinic, 83% of referrals for genetic testing for TMAU were deemed likely to instead have ORS. Findings found that the use of “fecal/sewage” as a description, and the use of multiple descriptors of the smell, and 'incorrect' locations of smell origin effectively differentiated ORS from TMAU. In the literature on body odour identification, emphasis is frequently placed on multiple consultations to reduce the risk of misdiagnosis, and also asking the individual to have a reliable confidant accompany them to the consultation who can confirm the reality of the reported symptom. ORS patients are unable to provide such confidants as they have no objective odor. [20] [21]

A fecal smell (fecal body odour) is often a self reported symptom associated with TMAU, [19] however there is no recorded evidence of fecal body odour present in any study related to TMAU. Cashman JR [22] found that 53% of TMAU and 59% of non-TMAU subjects suffered from regular halitosis, dental plaque on the back of the tongue, which produced on average "200-600 ppb of sulfurous/fecal smelling volatile sulfur compounds (i.e., VSC: hydrogen sulfide; methylmercaptan; dimethylsulfide) with each exhalation, creating a ‘malodorous cloud’ in their vicinity”. It is possible that other causes such as halitosis, haemorrhoids, bromhidrosis, ORS or in severe cases, a bowel obstruction leading to fecal vomiting may be the cause of fecal smells.

There is the possibility that someone may suffer from both Trimethylaminuria and ORS-like paranoia, due to the potential lack of ability to smell the odour oneself and the worry that it generates. It is recommended to organise reliable confidants, colleagues, friends or relatives ("odor buddies" [23] ) to work with the sufferer to discretely inform them if they are presenting an odour.

Affected individuals experience shame and embarrassment, fail to maintain relationships, avoid contact with people who comment on their condition, and are obsessive about masking the odour with hygiene products and even smoking. The malodorous aspect can have serious and destructive effects on schooling, personal life, career and relationships, resulting in social isolation, low self-esteem, depression, paranoid behaviour, and suicide. Delayed diagnosis, body odour and the lack of cure may lead to psychosocial issues. When the condition is suspected or known to occur in a family, genetic testing can be helpful in identifying the specific individuals who have or carry the disorder. [24]

The metabolic and clinical manifestations of TMAU are generally regarded as benign, as there is no associated organ dysfunction. This designation, and the fact that the condition is often unrecognised by doctors, misdiagnosed and can have important ramifications including missed or delayed diagnosis. [24]

Treatment

There is no known permanent cure for primary trimethylaminuria, but symptoms can in most cases be managed via diet, [25] and sometimes by certain supplements (as below).[ medical citation needed ]

Diet and supplement use should be overseen by medical professionals and nutritionists, as dietary restrictions can have other serious adverse health effects. Choline in particular is an essential nutrient required for proper neural formation in foetal and childhood development, if pregnant or breast-feeding a low choline diet should be avoided.

Ways of reducing the fishy odor may include:

Additionally, at least one study [32] has suggested that daily intake of the supplements activated charcoal and copper chlorophyllin may temporarily improve the quality of life of individuals afflicted with TMAU by helping their bodies to oxidize and convert TMA to the odorless N-oxide (TMAO) metabolite. Study participants experienced subjective reduction in odor as well as objective reduction in TMA and increase in TMAO concentration measured in their urine. The study found that:

Secondary Trimethylaminuria

Although FMO3 mutations account for most known cases of trimethylaminuria, some cases are caused by other factors.

A fish-like body odor can result from extreme excess consumption of TMA precursors such as choline, carnitine and betaine (usually unobtainable via regular dietary intake, it requires high levels of supplement intake). 900mg of trimethylamine, [33] 8g-20g of choline, [34] 3g of carnitine [35] or 20g betatine [36] has been known to cause temporary TMAU-like fish odour symptoms. These symptoms only last until supplement intake has ceased. Note, the RDI for choline is 450-550mg and most typical diets fall below this value, [37] so an excessive amount of precursor is required.

Two cases of the disorder have been identified in adults with liver damage caused by hepatitis. It is unknown if these cases were temporary or not as the individuals did not return for subsequent testing. [34]

In the case where someone is experiencing liver failure or kidney failure, [34] TMA is sometimes an element present as part of Fetor hepaticus, the "breath of the dead".

TMAU2 and gut dysbiosis

Between the years of 1997 and 2017, Sheffield Children's Hospital in England diagnosed several hundred people with TMAU2, and suggested the majority to be caused by dysbiosis in the gut. [38] There is no reference to scientific research confirming gut dysbiosis alone can cause TMAU2, and this type of diagnosis was not produced at other testing sites. Cases were claimed to be successfully cured with antibiotics and dietary changes as above. In 2017 a new gas chromatography machine [39] and testing procedure was introduced, which has far fewer false positive results, [40] [41] and very few (if any) TMAU2 results.

While the balance of gut bacteria does play a part in the amount of TMA being produced from precursors in the gut [42] (antibiotic treatment temporarily stops odour), gut bacteria in general convert a significant proportion of dietary TMA precursors already. For example, on average 63% of excess choline, and 31% of carnitine (+-13%) are converted to TMA [9] by an average gut profile - even if dysbiosis raised these values to 100%, it would still not meet the thresholds as above for precursor overload on a regular diet. TMAU2 by gut dysbiosis is currently a hypothetical [34] condition requiring further research.

History

The first clinical case of TMAU was described in 1970. [43] Her mother related that her child, a 6 year old girl, had intermittently had a peculiar "fishy" odour. Analysis of her urine showed an elevated level of trimethylamine, and that a chemically pure free base sample of trimethylamine smelled similar to the patient's fishy odor. They tested her condition by giving her more trimethylamine, which substantially increased her odour (which it did not in control subjects).

Notable media

In 2014, singer/songwriter Cassie Graves was first featured in the Daily Mail, the Daily Mirror, and The Metro UK newspapers in both print and Online, [44] giving an interview about her experiences with Trimethylaminuria. The article was later repurposed in media across the globe, most notably by HuffPost. [45]

In 2016, Graves was then featured in Princess Productions' Medical Mysteries on UK's Channel 5, which went on a journey to find an official diagnosis for the condition, and again sparked a global media interest in the condition.

The 2010 novel Boxer, Beetle by Ned Beauman features a character with trimethylaminuria.

British Internet personality Seaside Mark was diagnosed with trimethylaminuria, and has covered his experiences with the condition on his YouTube channel.

The 2023 film The Holdovers , directed by Alexander Payne, features a character with trimethylaminuria, although the condition was first described in the year in which the movie takes place.

Related Research Articles

<span class="mw-page-title-main">Choline</span> Chemical compound and essential nutrient

Choline ( KOH-leen) is an essential nutrient for humans and many other animals, which was formerly classified as a B vitamin (vitamin B4). It is a structural part of phospholipids and a methyl donor in metabolic one-carbon chemistry. The compound is related to trimethylglycine in the latter respect. It is a cation with the chemical formula [(CH3)3NCH2CH2OH]+. Choline forms various salts, for example choline chloride and choline bitartrate.

<span class="mw-page-title-main">Carnitine</span> Amino acid active in mitochondria

Carnitine is a quaternary ammonium compound involved in metabolism in most mammals, plants, and some bacteria. In support of energy metabolism, carnitine transports long-chain fatty acids from the cytosol into mitochondria to be oxidized for free energy production, and also participates in removing products of metabolism from cells. Given its key metabolic roles, carnitine is concentrated in tissues like skeletal and cardiac muscle that metabolize fatty acids as an energy source. Generally individuals, including strict vegetarians, synthesize enough L-carnitine in vivo.

B vitamins are a class of water-soluble vitamins that play important roles in cell metabolism and synthesis of red blood cells. They are a chemically diverse class of compounds; some contain sulfur and B12 contains cobalt. Dietary supplements containing all eight are referred to as a vitamin B complex. Individual B vitamins are referred to by B-number or by chemical name, such as B1 for thiamine, B2 for riboflavin, and B3 for niacin, while some are more commonly recognized by name than by number, such as pantothenic acid (B5), biotin (B7), and folate (B9).

Body odor or body odour (BO) is present in all animals and its intensity can be influenced by many factors. Body odor has a strong genetic basis, but can also be strongly influenced by various factors, such as sex, diet, health, and medication. The body odor of human males plays an important role in human sexual attraction, as a powerful indicator of MHC/HLA heterozygosity. Significant evidence suggests that women are attracted to men whose body odor is different from theirs, indicating that they have immune genes that are different from their own, which may produce healthier offspring.

<span class="mw-page-title-main">Cat food</span> Food for consumption by cats

Cat food is food specifically designed for consumption by cats. As obligate carnivores, cats have specific requirements for their dietary nutrients, namely nutrients found only in meat, such as taurine, arginine, and Vitamin B6. Certain nutrients, including many vitamins and amino acids, are degraded by the temperatures, pressures and chemical treatments used during manufacture, and hence must be added after manufacture to avoid nutritional deficiency.

<span class="mw-page-title-main">Trimethylamine</span> Chemical compound responsible for rotten fish odor

Trimethylamine (TMA) is an organic compound with the formula N(CH3)3. It is a trimethylated derivative of ammonia. TMA is widely used in industry. At higher concentrations it has an ammonia-like odor, and can cause necrosis of mucous membranes on contact. At lower concentrations, it has a "fishy" odor, the odor associated with rotting fish.

<span class="mw-page-title-main">Trimethylglycine</span> Chemical compound

Trimethylglycine is an amino acid derivative that occurs in plants. Trimethylglycine was the first betaine discovered; originally it was simply called betaine because, in the 19th century, it was discovered in sugar beets.

<span class="mw-page-title-main">Isovaleric acidemia</span> Medical condition disrupting normal metabolism

Isovaleric acidemia is a rare autosomal recessive metabolic disorder which disrupts or prevents normal metabolism of the branched-chain amino acid leucine. It is a classical type of organic acidemia.

<span class="mw-page-title-main">Maple syrup urine disease</span> Autosomal recessive metabolic disorder

Maple syrup urine disease (MSUD) is an autosomal recessive metabolic disorder affecting branched-chain amino acids. It is one type of organic acidemia. The condition gets its name from the distinctive sweet odor of affected infants' urine and earwax, particularly prior to diagnosis and during times of acute illness. It was described by John Menkes in the 1950s.

Glutaric acidemia type 1 (GA1) is an inherited disorder in which the body is unable to completely break down the amino acids lysine, hydroxylysine and tryptophan. Excessive levels of their intermediate breakdown products can accumulate and cause damage to the brain, but particularly the basal ganglia, which are regions that help regulate movement. GA1 causes secondary carnitine deficiency, as glutaric acid, like other organic acids, is detoxified by carnitine. Mental retardation may occur.

Trimethylamine <i>N</i>-oxide Chemical compound

Trimethylamine N-oxide (TMAO) is an organic compound with the formula (CH3)3NO. It is in the class of amine oxides. Although the anhydrous compound is known, trimethylamine N-oxide is usually encountered as the dihydrate. Both the anhydrous and hydrated materials are white, water-soluble solids.

<span class="mw-page-title-main">Flavin-containing monooxygenase 3</span> Protein-coding gene in the species Homo sapiens

Flavin-containing monooxygenase 3 (FMO3), also known as dimethylaniline monooxygenase [N-oxide-forming] 3 and trimethylamine monooxygenase, is a flavoprotein enzyme (EC 1.14.13.148) that in humans is encoded by the FMO3 gene. This enzyme catalyzes the following chemical reaction, among others:

Trimethylamine N-oxide reductase is a microbial enzyme that can reduce trimethylamine N-oxide (TMAO) into trimethylamine (TMA), as part of the electron transport chain. The enzyme has been purified from E. coli and the photosynthetic bacteria Roseobacter denitrificans.

<span class="mw-page-title-main">TAAR5</span> Protein-coding gene in the species Homo sapiens

Trace amine-associated receptor 5 is a protein that in humans is encoded by the TAAR5 gene. In vertebrates, TAAR5 is expressed in the olfactory epithelium.

<span class="mw-page-title-main">Flavin containing monooxygenase 1</span> Protein-coding gene in the species Homo sapiens

Dimethylaniline monooxygenase [N-oxide-forming] 1 is an enzyme that in humans is encoded by the FMO1 gene.

<span class="mw-page-title-main">FMO4</span> Protein-coding gene in the species Homo sapiens

Dimethylaniline monooxygenase [N-oxide-forming] 4 is an enzyme that in humans is encoded by the FMO4 gene.

<span class="mw-page-title-main">Animal source foods</span>

Animal source foods (ASF) include many food items that come from an animal source such as fish, meat, dairy, eggs and honey. Many individuals consume little ASF or even none for long periods of time by either personal choice or necessity, as ASF may not be accessible or available to these people.

<span class="mw-page-title-main">Flavin-containing monooxygenase</span> Class of enzymes

The flavin-containing monooxygenase (FMO) protein family specializes in the oxidation of xeno-substrates in order to facilitate the excretion of these compounds from living organisms. These enzymes can oxidize a wide array of heteroatoms, particularly soft nucleophiles, such as amines, sulfides, and phosphites. This reaction requires an oxygen, an NADPH cofactor, and an FAD prosthetic group. FMOs share several structural features, such as a NADPH binding domain, FAD binding domain, and a conserved arginine residue present in the active site. Recently, FMO enzymes have received a great deal of attention from the pharmaceutical industry both as a drug target for various diseases and as a means to metabolize pro-drug compounds into active pharmaceuticals. These monooxygenases are often misclassified because they share activity profiles similar to those of cytochrome P450 (CYP450), which is the major contributor to oxidative xenobiotic metabolism. However, a key difference between the two enzymes lies in how they proceed to oxidize their respective substrates; CYP enzymes make use of an oxygenated heme prosthetic group, while the FMO family utilizes FAD to oxidize its substrates.

<span class="mw-page-title-main">3,3-Dimethyl-1-butanol</span> Chemical compound

3,3-Dimethyl-1-butanol (DMB) is a structural analog of choline.

Intestinal metabolic bromhidrosis syndrome (IMBS) is a disorder, that is characterized by bromhidrosis and halitosis symptoms that are caused by odorous intestinal metabolites passing through the intestinal wall and by the liver to be excreted by skin glands and the lung gas exchange.

References

  1. Mitchell SC, Smith RL (2001). "Trimethylaminuria: the fish malodor syndrome". Drug Metab Dispos. 29 (4 Pt 2): 517–21. PMID   11259343.
  2. Treacy EP, et al. (1998). "Mutations of the flavin-containing monooxygenase gene (FMO3) cause trimethylaminuria, a defect in detoxication". Human Molecular Genetics. 7 (5): 839–45. doi: 10.1093/hmg/7.5.839 . PMID   9536088.
  3. Zschocke J, Kohlmueller D, Quak E, Meissner T, Hoffmann GF, Mayatepek E (1999). "Mild trimethylaminuria caused by common variants in FMO3 gene". Lancet. 354 (9181): 834–5. doi:10.1016/S0140-6736(99)80019-1. PMID   10485731. S2CID   9555588.
  4. "Office of Dietary Supplements - Choline". ods.od.nih.gov. Retrieved 2023-04-16.
  5. 1 2 Schmidt AC, Leroux JC (2020). "Treatments of trimethylaminuria: where we are and where we might be heading". Drug Discov Today. 25 (9): 1710–1717. doi: 10.1016/j.drudis.2020.06.026 . hdl: 20.500.11850/423705 . PMID   32615074. S2CID   220329737.
  6. Kalnins G, Kuka J, Grinberga S, Makrecka-Kuka M, Liepinsh E, Dambrova M, Tars K (August 2015). "Structure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae". Journal of Biological Chemistry. 290 (35): 21732–21740. doi: 10.1074/jbc.M115.670471 . PMC   4571895 . PMID   26187464.
  7. Janeiro MH, Ramírez MJ, Milagro FI, Martínez JA, Solas M (2018). "Implication of Trimethylamine N-Oxide (TMAO) in Disease: Potential Biomarker or New Therapeutic Target". Nutrients. 10 (10): 1398. doi: 10.3390/nu10101398 . PMC   6213249 . PMID   30275434.
  8. 1 2 Crimarco A, Springfield S, Petlura C, Streaty T, Cunanan K, Lee J, Fielding-Singh P, Carter MM, Topf MA, Wastyk HC, Sonnenburg ED, Sonnenburg JL, Gardner CD (2020). "A randomized crossover trial on the effect of plant-based compared with animal-based meat on trimethylamine-N-oxide and cardiovascular disease risk factors in generally healthy adults: Study With Appetizing Plantfood-Meat Eating Alternative Trial (SWAP-MEAT)". Am J Clin Nutr. 112 (5): 1188–1199. doi:10.1093/ajcn/nqaa203. PMC   7657338 . PMID   32780794.
  9. 1 2 3 Zhang AQ, Mitchell SC, Smith RL (May 1999). "Dietary precursors of trimethylamine in man: a pilot study". Food and Chemical Toxicology. 37 (5): 515–520. doi:10.1016/s0278-6915(99)00028-9. ISSN   0278-6915. PMID   10456680.
  10. Manning NJ, Allen EK, Kirk RJ, Sharrard MJ, Smith EJ (2011-11-20). "Riboflavin-Responsive Trimethylaminuria in a Patient with Homocystinuria on Betaine Therapy". JIMD Reports. 5: 71–75. doi:10.1007/8904_2011_99. ISBN   978-3-642-28095-5. ISSN   2192-8304. PMC   3509925 . PMID   23430919.
  11. Wise PM, Eades J, Tjoa S, Fennessey PV, Preti G (2011). "Individuals reporting idiopathic malodor production: demographics and incidence of trimethylaminuria". Am. J. Med. 124 (11): 1058–1063. doi:10.1016/j.amjmed.2011.05.030. PMID   21851918.
  12. 1 2 "Learning About Trimethylaminuria" . Retrieved 25 April 2016.
  13. Hernandez D, Addou S, Lee D, Orengo C, Shephard EA, Phillips IR (2003). "Trimethylaminuria and a human FMO3 mutation database". Hum Mutat. 22 (3): 209–13. doi: 10.1002/humu.10252 . PMID   12938085. S2CID   5965257.
  14. Furnes B, Feng J, Sommer SS, Schlenk D (2003). "Identification of novel variants of the flavin-containing monooxygenase gene family in African Americans". Drug Metab Dispos. 31 (2): 187–93. doi:10.1124/dmd.31.2.187. PMID   12527699. S2CID   6619389.
  15. Guo, Y., Hwang, L. D., Li, J., Eades, J., Yu, C. W., Mansfield, C., ... & Preti, G. (2017). Genetic analysis of impaired trimethylamine metabolism using whole exome sequencing. BMC medical genetics, 18(1), 1-9.
  16. Allerston CK, Shimizu M, Fujieda M, Shephard EA, Yamazaki H, Phillips IR (2007). "Molecular evolution and balancing selection in the flavin-containing monooxygenase 3 gene (FMO3)". Pharmacogenet Genomics. 17 (10): 827–39. doi:10.1097/FPC.0b013e328256b198. PMID   17885620. S2CID   6712355.
  17. 1 2 3 4 Shephard EA, Treacy, Eileen P, Phillips, Ian R (30 November 2011). "Clinical utility gene card for: Trimethylaminuria". European Journal of Human Genetics. 20 (3): 4–5. doi:10.1038/ejhg.2011.214. PMC   3283181 . PMID   22126753.
  18. Lenherr N, Berndt A, Ritz N, Rudin C. Aerococcus urinae: a possible reason for malodorous urine in otherwise healthy children. Eur J Pediatr. 2014;173:1115-7; Gibb AP, Sivaraman B. A second case of foul smelling urine in a boy caused by Aerococcus urinae. Pediatr Infect Dis J. 2013;32:1300-1.
  19. 1 2 McNiven V, Mamane S, et al. (2019). "The Nose Knows… or Does it? Olfactory Reference Syndrome in Patients Presenting for Assessment of Unusual Body Odor". J Nerv Ment Dis. 207 (3): 145–151. doi:10.1097/NMD.0000000000000933. PMID   30720598. S2CID   73434719.
  20. Richter JL (Apr 1996). "Diagnosis and treatment of halitosis". Compendium of Continuing Education in Dentistry. 17 (4): 370–2, 374–6 passim, quiz 388. PMID   9051972.
  21. Newman MG, Takei HH, Klokkevold PR, Carranza FA, eds. (2012). Carranza's clinical periodontology (11th ed.). St. Louis, Mo.: Elsevier/Saunders. pp. 1333, 1334. ISBN   978-1-4377-0416-7.
  22. Cashman JR, Camp K, Fakharzadeh SS, Fennessey PV, Hines RN, Mamer OA, Mitchell SC, Nguyen GP, Schlenk D, Smith RL, Tjoa SS, Williams DE, Yannicelli S (2003). "Biochemical and clinical aspects of the human flavin-containing monooxygenase form 3 (FMO3) related to trimethylaminuria". Curr Drug Metab. 4 (2): 151–170. doi:10.2174/1389200033489505. PMID   12678693.
  23. Trimethylaminuria (TMAU): history, diagnosis and genetics , retrieved 2023-10-02
  24. 1 2 Mountain H, Brisbane JM, Hooper AJ, Burnett JR, Goldblatt J (2008). "Trimethylaminuria (fish malodour syndrome): a "benign" genetic condition with major psychosocial sequelae". Med. J. Aust. 189 (8): 468. doi:10.5694/j.1326-5377.2008.tb02126.x. PMID   18928446. S2CID   35200507.
  25. Kloster I, Erichsen MM (September 2021). "Trimethylaminuria". Tidsskr Nor Laegeforen. 141. doi: 10.4045/tidsskr.21.0142 . PMID   34597008.
  26. Bockus AB, Seibel BA (2016-06-01). "Trimethylamine oxide accumulation as a function of depth in Hawaiian mid-water fishes". Deep Sea Research Part I: Oceanographic Research Papers. 112: 37–44. Bibcode:2016DSRI..112...37B. doi: 10.1016/j.dsr.2016.03.005 . ISSN   0967-0637.
  27. Demarquoy J, Georges B, Rigault C, Royer MC, Clairet A, Soty M, Lekounoungou S, Le Borgne F (2004). "Radioisotopic determination of l-carnitine content in foods commonly eaten in Western countries". Food Chemistry. 86 (1): 137–142. doi:10.1016/j.foodchem.2003.09.023.
  28. Wang Z, Bergeron N, Levison BS, Li XS, Chiu S, Jia X, Koeth RA, Li Y, Wu Y, Tang WH, Krauss RM, Hazen SL (2019). "Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women". European Heart Journal. 40 (7): 583–594. doi:10.1093/eurheartj/ehy799. PMC   6374688 . PMID   30535398.
  29. 1 2 "Choline : USDA ARS". www.ars.usda.gov. Retrieved 2022-09-19.
  30. Bouchemal N, Ouss L, Brassier A, Barbier V, Gobin S, Hubert L, de Lonlay P, Le Moyec L (2019). "Diagnosis and phenotypic assessment of trimethylaminuria, and its treatment with riboflavin: 1H NMR spectroscopy and genetic testing". Orphanet J Rare Dis. 18 (1): 14(1):222. doi: 10.1186/s13023-019-1174-6 . PMC   6751875 . PMID   31533761.
  31. Treacy E, Johnson D, Pitt JJ, Danks DM (1995). "Trimethylaminuria, fish odour syndrome: A new method of detection and response to treatment with metronidazole". J Inherit Metab Dis. 18 (3): 306–312. doi:10.1007/bf00710420. PMID   7474897. S2CID   42397848.
  32. Yamazaki H, Fujieda M, Togashi M, et al. (2004). "Effects of the dietary supplements, activated charcoal and copper chlorophyllin, on urinary excretion of trimethylamine in Japanese trimethylaminuria patients". Life Sci. 74 (22): 2739–2747. doi:10.1016/j.lfs.2003.10.022. PMID   15043988.
  33. al-Waiz M, Ayesh R, Mitchell SC, Idle JR, Smith RL (1989). "Trimethylaminuria: the detection of carriers using a trimethylamine load test". Journal of Inherited Metabolic Disease. 12 (1): 80–85. doi:10.1007/BF01805534. ISSN   0141-8955. PMID   2501587. S2CID   22725501.
  34. 1 2 3 4 Mackay RJ, McEntyre CJ, Henderson C, Lever M, George PM (2011). "Trimethylaminuria: causes and diagnosis of a socially distressing condition". The Clinical Biochemist. Reviews. 32 (1): 33–43. ISSN   1838-0212. PMC   3052392 . PMID   21451776.
  35. "Office of Dietary Supplements - Carnitine". ods.od.nih.gov. Retrieved 2023-10-02.
  36. Manning NJ, Allen EK, Kirk RJ, Sharrard MJ, Smith EJ (2012). "Riboflavin-responsive trimethylaminuria in a patient with homocystinuria on betaine therapy". JIMD Reports. 5: 71–75. doi:10.1007/8904_2011_99. ISBN   978-3-642-28095-5. ISSN   2192-8304. PMC   3509925 . PMID   23430919.
  37. "Office of Dietary Supplements - Choline". ods.od.nih.gov. Retrieved 2023-10-02.
  38. Manning N. "TMAU – diagnostic testing at Sheffield Children's Hospital" (PDF).
  39. blogcontributor2. "Sheffield TMAU test back : And new ref ranges" . Retrieved 2023-10-02.{{cite web}}: |last= has generic name (help)CS1 maint: numeric names: authors list (link)
  40. sysbodyodor. "Comment on the NEW UK TMAU Test (Sheffield)" . Retrieved 2023-10-02.
  41. blogcontributor2. "UK TMAU Test Stats 2017-2021 : Activist uses FOI act" . Retrieved 2023-10-02.{{cite web}}: |last= has generic name (help)CS1 maint: numeric names: authors list (link)
  42. Fraser-Andrews EA, Manning NJ, Ashton GH, Eldridge P, McGrath J, Menagé Hd (2003). "Fish odour syndrome with features of both primary and secondary trimethylaminuria". Clinical and Experimental Dermatology. 28 (2): 203–205. doi:10.1046/j.1365-2230.2003.01230.x. ISSN   0307-6938. PMID   12653714. S2CID   42075440.
  43. Humbert JA, Hammond KB, Hathaway WE (1970). "Trimethylaminuria: the fish-odour syndrome". Lancet. 2 (7676): 770–1. doi:10.1016/S0140-6736(70)90241-2. PMID   4195988.
  44. Reporter MN (July 2, 2014). "Rare condition leaves singer smelling of rotting fish".
  45. "'I Smell Like Rotting Fish': Woman Has Rare Fish Odour Syndrome". HuffPost UK. July 3, 2014.

This article incorporates public domain text from The U.S. National Library of Medicine and The National Human Genome Research Institute